Brian T. Powl Kura Oncology, Inc. (KURA) insider trading activity

Brian T. Powl is Chief Commercial Officer of Kura Oncology, Inc.. Currently has a direct ownership of 189,689 shares of KURA, which is worth approximately $2.12 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 190K

90.31% 3M change

209.7% 12M change

Total Value Held $2.12 Million

Brian T. Powl Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	50,000 Added 20.86%	189,689 Common Stock
Nov 14 2025	SELL Open market or private sale	$99,356 $11.18 p/Share	8,887 Reduced 5.98%	139,689 Common Stock
Nov 13 2025	BUY Grant, award, or other acquisition	-	48,900 Added 24.76%	148,576 Common Stock
Sep 29 2025	SELL Open market or private sale	$79,485 $8.94 p/Share	8,891 Reduced 8.19%	99,676 Common Stock
Sep 27 2025	BUY Grant, award, or other acquisition	-	48,900 Added 31.05%	108,567 Common Stock
Jan 28 2025	SELL Open market or private sale	$12,458 $7.87 p/Share	1,583 Reduced 2.58%	59,667 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	46,250 Added 43.02%	61,250 Common Stock

Jan 02 2024	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Common Stock

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

Chief Commercial Officer

BTP

Brian T. Powl

Chief Commercial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Value

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kura Oncology, Inc.

Track Activities on KURA

Account